Intech Investment Management LLC Takes Position in LifeMD, Inc. (NASDAQ:LFMD)

Intech Investment Management LLC acquired a new stake in shares of LifeMD, Inc. (NASDAQ:LFMD) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 10,287 shares of the company’s stock, valued at approximately $54,000.

A number of other institutional investors have also bought and sold shares of LFMD. Quest Partners LLC acquired a new position in LifeMD during the second quarter worth $31,000. nVerses Capital LLC purchased a new stake in shares of LifeMD in the third quarter valued at about $46,000. CWM LLC acquired a new stake in LifeMD during the third quarter worth about $59,000. SG Americas Securities LLC purchased a new position in LifeMD during the third quarter worth about $70,000. Finally, Los Angeles Capital Management LLC acquired a new position in LifeMD in the 2nd quarter valued at about $88,000. 35.52% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently commented on LFMD. B. Riley started coverage on LifeMD in a report on Friday, August 23rd. They issued a “buy” rating and a $11.00 price objective on the stock. Mizuho started coverage on shares of LifeMD in a report on Wednesday, December 4th. They issued a “neutral” rating and a $7.00 price objective on the stock. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $15.00 target price on shares of LifeMD in a research note on Friday, September 20th. Finally, HC Wainwright reissued a “buy” rating and issued a $12.00 price target on shares of LifeMD in a research note on Monday, November 11th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $11.50.

LifeMD Price Performance

Shares of NASDAQ LFMD opened at $5.58 on Monday. The stock’s 50-day moving average is $5.22 and its two-hundred day moving average is $5.94. The company has a debt-to-equity ratio of 10.83, a current ratio of 0.83 and a quick ratio of 0.78. The company has a market cap of $241.67 million, a price-to-earnings ratio of -8.72 and a beta of 1.38. LifeMD, Inc. has a 1-year low of $3.99 and a 1-year high of $12.88.

Insider Buying and Selling

In related news, CEO Justin Schreiber sold 25,000 shares of the business’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $6.52, for a total transaction of $163,000.00. Following the completion of the transaction, the chief executive officer now owns 2,728,715 shares in the company, valued at approximately $17,791,221.80. The trade was a 0.91 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 15.97% of the company’s stock.

LifeMD Company Profile

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.